Back to News
research

Peptides and bioelectronics for cardiac cell therapy

Nature Quantum Materials
Loading...
3 min read
1 views
0 likes
Peptides and bioelectronics for cardiac cell therapy

Summarize this article with:

Access through your institution Buy or subscribe Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a promising platform to treat cardiac pathologies, namely infarcted tissue. Current methods for the transplantation of hiPSC-CMs into the heart often result in differentiated cells that do not fully mimic the phenotype, properties and functions of developed cardiac cells. Thus, to realize the clinical potential of hiPSC-CMs, safe and effective transplantation strategies are needed. Now, writing in Science, Richard Lee, Jia Liu and colleagues (Science 390, eadw4612; 2025) report injectable, self-assembling peptides that create a suitable microenvironment for the differentiation of transplanted hiPSC-CMs in the rat heart and whose functionality is measured using a bioelectronic device.A common issue with hiPSC-CM transplantation is the spontaneous arrhythmogenic automaticity of the implanted tissue, which can result in deadly complications. Lee and colleagues design a flexible biooelectronic mesh with 32 channels that can obtain electrophysiological recordings with high spatiotemporal resolution from hiPSC-CM and native cardiac tissue. Sinus rhythms are measured for the hiPSC-CMs alone and hiPSC-CMs with RADA16 injection sites. Whereas the hiPSC-CMs alone sites generate arrhythmogenic automaticity rhythms, these undesired rhythms are not detected for the hiPSC-CMs with RADA16 sites. Longitudinal electrophysiology studies show that integration of hiPSC-CMs with RADA16 promotes a faster reduction of the percentage of arrhythmogenic automaticity compared with hiPSC-CMs. Moreover, at 135 days post-transplantation, the electrophysiology of hiPSC-CMs with RADA16 sites resembles that of the reference site in the rat heart. This is a preview of subscription content, access via your institution Access options Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Rent or buy this article Prices vary by article type from$1.95 to$39.95 Learn more Prices may be subject to local taxes which are calculated during checkout Author informationAuthors and AffiliationsNature Materials https://www.nature.com/nmat/Bruno CastroAuthorsBruno CastroView author publicationsSearch author on:PubMed Google ScholarCorresponding authorCorrespondence to Bruno Castro.Rights and permissionsReprints and permissionsAbout this articleCite this articleCastro, B. Peptides and bioelectronics for cardiac cell therapy. Nat. Mater. (2025). https://doi.org/10.1038/s41563-025-02453-xDownload citationPublished: 17 December 2025Version of record: 17 December 2025DOI: https://doi.org/10.1038/s41563-025-02453-xShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy shareable link to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

Read Original

Source Information

Source: Nature Quantum Materials